Updated July-2026-24

Mounjaro Patient Assistance Program: Eligibility & How to Apply

Evan Brown
Written by Evan Brown
Medical Content Researcher
Dr Megan Harris Medically Reviewed by Dr. Megan Harris, MD
Verified August 7, 2026: We checked the official Lilly Cares medication list and confirmed Mounjaro is not currently covered. Program terms change — always verify directly with Lilly before applying.

How to Afford Mounjaro in 2026: Savings Card, LillyDirect & Discount Options

Mounjaro (tirzepatide) costs approximately $1,079.77 per month at list price without insurance. Unlike many Eli Lilly medications, Mounjaro is not covered by the Lilly Cares Foundation Patient Assistance Program as of August 7, 2026. That leaves three real paths to reduce the cost: the Mounjaro Savings Card for commercially insured patients, LillyDirect self-pay pricing, and third-party pharmacy discount cards.

Mounjaro Cost Without Insurance: August 2026

OptionMonthly CostAnnual Cost
List price (no discounts)~$1,080~$13,000
GoodRx / SingleCare discount~$995~$11,940
LillyDirect self-pay~$1,080~$13,000
Mounjaro Savings Card (commercial insurance, covered)As low as $25Up to $1,950 savings cap
Mounjaro Savings Card (commercial insurance, NOT covered)As low as $499Up to $8,411 savings cap

Mounjaro Savings Card Phone Number: 1-833-807-MJRO (1-833-807-6576). Enrollment: mounjaro.lilly.com/savings-resources or text "MJ" to 85099.

Quick Facts

QuestionAnswer (August 2026)
Does Lilly Cares cover Mounjaro?No
Is there a free Mounjaro program?No
Cheapest option with insurance$25/month (Savings Card)
Cheapest option without insurance~$995/month (discount card)
List price$1,079.77/month
This guide breaks down each specific way to afford Mounjaro, who each option is actually for, and how to avoid applying to the wrong one.

Table of Contents

  1. Three Ways to Afford Mounjaro: A Side-by-Side Comparison
  2. The Mounjaro Savings Card
  3. The Lilly Cares Foundation Patient Assistance Program
  4. Why Mounjaro's Medicare Coverage Differs From Weight-Loss GLP-1s
  5. Mounjaro vs Zepbound: Why Indication Changes Everything
  6. LillyDirect Self-Pay Pricing
  7. Required Documents for Lilly Cares
  8. How to Apply, Step by Step
  9. How Long Approval Takes
  10. What to Do If You're Denied
  11. Frequently Asked Questions

Three Ways to Afford Mounjaro: A Side-by-Side Comparison

Before applying anywhere, figure out which category fits your situation. This decision alone saves most patients weeks of wasted paperwork.

Program Who It's For Income-Based? Requires Existing Coverage?
Mounjaro Savings Card Commercially insured patients whose plan covers Mounjaro No Yes
Lilly Cares Foundation Uninsured/underinsured, income-qualifying patients Yes No — designed for those without adequate coverage
LillyDirect Self-Pay Patients paying cash, regardless of insurance status No No

Quick gut check: If your insurance already covers Mounjaro but the copay is high, start with the savings card. If you have no coverage or a formulary exclusion, compare the Lilly Cares income requirements against LillyDirect's self-pay price before deciding which path to pursue.

The Mounjaro Savings Card

This program is a copay reduction tool, not a source of free medication. It only works when your insurance plan has already agreed to cover Mounjaro in some form.

Feature Detail
Who Qualifies Commercially insured patients with Mounjaro coverage on their plan
What It Reduces Copay or coinsurance amount at the pharmacy
Income Requirement None
Medicare/Medicaid Not eligible — federal program restriction

If your plan doesn't cover Mounjaro at all (a formulary exclusion, not just a high copay), the savings card won't help — you'll need a formulary exception, the Lilly Cares Foundation, or LillyDirect instead.

Mounjaro Savings Card: Who Qualifies in 2026

  • Commercial insurance required. The card does not work for uninsured, Medicare, Medicaid, or TRICARE patients.
  • Type 2 diabetes diagnosis required. Off-label weight-loss prescriptions are excluded — use Zepbound's card instead.
  • Two tiers: $25/month if your plan covers Mounjaro; ~$499/month if your plan excludes it.
  • Caps: $150/month savings (covered tier) or $647/month (non-covered tier). Annual caps: $1,950 and $8,411.
  • 13 fills per year. A "month" = 28 days, up to 4 pens.
  • Expires: December 31, 2026.

How to Get Mounjaro for $25 a Month

The $25 price is only available through the Mounjaro Savings Card for patients whose commercial insurance already covers Mounjaro. It is not available to uninsured patients. Here's the exact process:

  1. Confirm your plan covers Mounjaro for type 2 diabetes (not weight loss).
  2. Enroll at mounjaro.lilly.com/savings-resources or text "MJ" to 85099.
  3. Present the digital or printed card at the pharmacy with your insurance.
  4. Verify your copay is $25 before paying.

Uninsured patients: You cannot use the $25 savings card. Your best options are LillyDirect self-pay or asking your doctor about Zepbound vials, which start at $299/month through LillyDirect for weight loss.

Why Lilly Cares Does Not Cover Mounjaro

As of August 7, 2026, the Lilly Cares Foundation medication list focuses on insulin products, select oncology and immunology therapies, and a limited set of other high-need medicines — Mounjaro is not on the list. This means uninsured patients cannot get free Mounjaro through Lilly Cares regardless of income.

What this means for you: If you are uninsured and cannot afford Mounjaro, your options are LillyDirect self-pay pricing, third-party discount cards, or asking your doctor about alternative GLP-1 medications that are covered by patient assistance programs.

Why Mounjaro's Medicare Coverage Differs From Weight-Loss GLP-1s

This is the single biggest difference between Mounjaro and its weight-management cousins. Because Mounjaro's FDA-approved use is treating type 2 diabetes, it fits within Medicare Part D's traditional coverage categories in a way that weight-loss-only medications historically have not.

Medication FDA-Approved Use Typical Medicare Part D Coverage
Mounjaro Type 2 Diabetes Often Covered (subject to plan formulary and PA)
Zepbound Chronic Weight Management Not Covered for Weight Loss Alone

Why this matters: A patient with type 2 diabetes prescribed Mounjaro has a meaningfully better shot at Medicare Part D coverage than a patient without diabetes seeking a tirzepatide product purely for weight loss, even though the medication itself is nearly identical.

Mounjaro vs Zepbound: Why Indication Changes Everything

Both products are made by Eli Lilly and share the same active ingredient, tirzepatide, but they are FDA-approved for different conditions. That single difference cascades into everything from formulary placement to Medicare eligibility to prior authorization criteria.

Factor Mounjaro Zepbound
FDA-Approved Indication Type 2 Diabetes Chronic Weight Management
Typical Prior Auth Criteria A1C, diabetes diagnosis, step therapy with metformin BMI, comorbidity documentation
Medicare Part D Often Covered Generally Excluded for Weight Loss
Lilly Cares Eligibility Requires diabetes diagnosis Requires weight-management indication and criteria

If your insurance denies Mounjaro because your chart shows a weight-management goal rather than a diabetes diagnosis, that's a documentation and indication issue, not necessarily a sign the medication itself isn't covered by your plan.

LillyDirect Self-Pay Pricing

Separate from both programs above, Lilly offers a self-pay purchasing channel through LillyDirect, giving patients a set cash price outside the insurance system entirely.

Feature Detail
Who It's For Patients without adequate coverage, or who prefer paying cash
Income Requirement None
Insurance Requirement None — works independently of insurance status
How to Access Directly through the LillyDirect platform with a valid prescription

Self-pay pricing can be a reasonable bridge option while a prior authorization or Lilly Cares application is pending, since it doesn't require waiting on an approval decision the way the charity program does.

Required Documents for Lilly Cares

Document Purpose
Completed patient section of application Confirms identity, address, household size and insurance status
Completed prescriber section of application Confirms type 2 diabetes diagnosis and medical necessity
Proof of income Recent tax return, pay stubs, or benefits statement
Proof of insurance status Insurance card, denial letter, or evidence of no drug coverage
Valid prescription Confirms dose and formulation requested

Step-by-Step: How to Apply to Lilly Cares

1

Confirm your indication matches the program

Lilly Cares eligibility for Mounjaro is tied to a type 2 diabetes diagnosis — confirm this is documented in your chart before applying.

2

Request the application

Applications are available through the Lilly Cares Foundation's materials or by phone, and are often provided directly by your prescriber's office.

3

Complete the patient section

Fill in your personal information, household size, income, and current insurance status.

4

Have your prescriber complete their section

Your provider confirms your type 2 diabetes diagnosis, the prescribed dose, and medical necessity.

5

Attach income and insurance documentation

Include recent proof of income and documentation showing your lack of adequate prescription coverage.

6

Submit and await a decision

Applications are typically submitted by fax or mail. You'll receive written notification of approval or denial with next steps.

How Long Approval Takes

Situation Typical Timeframe
Mounjaro Savings Card (already covered by insurance) Immediate at the pharmacy counter
LillyDirect self-pay Immediate, order-dependent
Lilly Cares, complete application 2–4 weeks
Lilly Cares, missing documents Additional 2–3 weeks after resubmission

Decision Tree: Which Program Should You Use?

Step 1: Does your insurance already cover Mounjaro, just with a high copay?

✔ Yes → Use the Mounjaro Savings Card if you have commercial insurance.

✖ No → Continue to Step 2.


Step 2: Is your household income within the Lilly Cares limit and do you have a documented type 2 diabetes diagnosis?

✔ Yes → Apply to the Lilly Cares Foundation.

✖ No → Continue to Step 3.


Step 3: Do you need medication now while other options are pending, or does neither program fit?

✔ Yes → Check LillyDirect self-pay pricing as a bridge or standalone option.


What to Do If You're Denied

Reason for Denial What It Means Next Step
Income above Lilly Cares threshold Household income exceeds the foundation's limit Compare LillyDirect self-pay pricing against your insurance's cash price
Missing documentation Application was incomplete Resubmit with all required documents attached
No documented diabetes diagnosis Chart reflects weight-management goals rather than type 2 diabetes Discuss documentation with your prescriber, or ask about Zepbound-specific programs instead
Existing adequate coverage Program considers your current insurance sufficient Use the Mounjaro Savings Card instead, if commercially insured

Alternative Assistance Options

Resource What It Offers
Independent Diabetes-Focused Foundations Copay and supply assistance grants for qualifying diagnoses
State Pharmaceutical Assistance Programs State-run supplemental drug coverage for eligible residents
Hospital or Clinic Charity Care Programs Discounted or free medication access through your care site
340B-Participating Clinics Reduced-cost medication access for patients treated at qualifying clinics

Common Mistakes That Delay Getting Affordable Mounjaro

  • □ Using the Savings Card while enrolled in Medicare or Medicaid (not eligible).
  • □ Applying to Lilly Cares without a documented type 2 diabetes diagnosis on file.
  • □ Prescriber section left blank or unsigned.
  • □ Income documentation doesn't match household size.
  • □ Assuming Zepbound's coverage rules automatically apply to Mounjaro, or vice versa.
  • □ Outdated income documents older than the program's accepted window.
  • □ Renewal submitted after the enrollment period already lapsed.

Most of these issues are simple documentation mismatches. Confirming your diagnosis, insurance status, and correct program before applying avoids weeks of unnecessary delay.


Quick Checklist Before You Apply to Lilly Cares

Checklist Item Status
Confirmed the Savings Card or LillyDirect won't solve the issue first
Type 2 diabetes diagnosis documented
Patient section fully completed
Prescriber section signed and completed
Recent proof of income attached
Proof of insurance status attached

Bottom Line

Affording Mounjaro comes down to matching your specific insurance and income situation to the right program. Commercially insured patients with coverage already in place should start with the Mounjaro Savings Card. Uninsured or underinsured patients with a documented type 2 diabetes diagnosis and qualifying income should apply to the Lilly Cares Foundation. Anyone who needs a bridge option, or doesn't fit either program, can check LillyDirect's self-pay pricing.

Because Mounjaro's diabetes indication gives it a real shot at Medicare Part D coverage — unlike weight-loss-only GLP-1 medications — Medicare patients specifically should push for that coverage path first, with prior authorization documentation, before assuming they're stuck paying full price.


Frequently Asked Questions

No. As of August 2026, Eli Lilly's Lilly Cares Foundation does not include Mounjaro on its list of covered medications. Uninsured patients cannot get free Mounjaro through Lilly Cares regardless of income.

Mounjaro's list price is approximately $1,079.77 per month for a 28-day supply (4 pens). With third-party discount cards like GoodRx or SingleCare, cash prices typically range from $995 to $1,200 depending on pharmacy and location.

The $25 monthly price is only available through the Mounjaro Savings Card for patients with commercial insurance that covers Mounjaro for type 2 diabetes. Enroll at mounjaro.lilly.com/savings-resources or text 'MJ' to 85099. Uninsured and government-insured patients are not eligible.

No. The Mounjaro Savings Card requires commercial insurance. It does not apply to uninsured, Medicare, Medicaid, or TRICARE patients. Uninsured patients should explore LillyDirect self-pay pricing or third-party discount cards instead.

The Mounjaro Savings Card program can be reached at 1-833-807-MJRO (1-833-807-6576). You can also enroll online at mounjaro.lilly.com/savings-resources or by texting 'MJ' to 85099.

Many Medicare Part D plans cover Mounjaro when prescribed for type 2 diabetes, since that is its FDA-approved indication, though prior authorization and step therapy requirements still commonly apply.

The Mounjaro Savings Card reduces out-of-pocket costs for commercially insured patients whose plan already covers Mounjaro, while the Patient Assistance Program provides the medication at no cost to eligible uninsured or underinsured, income-qualifying patients.

Mounjaro and Zepbound both contain tirzepatide and are made by Eli Lilly, but Mounjaro is FDA-approved for type 2 diabetes while Zepbound is FDA-approved for chronic weight management, which means they can have different insurance coverage rules even though the medication itself is similar.

Lilly offers self-pay purchasing options through LillyDirect for eligible patients, providing a set cash price that can be lower than the full list price for those without adequate insurance coverage.

No. Federal restrictions generally prevent Medicare and Medicaid beneficiaries from using manufacturer copay cards. Medicare patients should instead pursue Part D coverage directly or check Lilly Cares Foundation eligibility.

Common reasons include missing step therapy documentation (such as a prior metformin trial), an incomplete prior authorization submission, or a formulary exclusion at the plan level. Reviewing the specific denial reason with your prescriber is the fastest way to identify next steps.

Yes. Enrollment is typically granted for a set period, often around 12 months, after which you must reapply and resubmit updated income and insurance documentation.

If your household income exceeds the foundation's threshold, LillyDirect self-pay pricing and independent diabetes-focused foundations are worth exploring as alternatives, since neither requires meeting the same income criteria.

No. Because each product has its own approved indication and program criteria, switching prescriptions generally means starting a new application process for whichever program matches the new medication.

A change in insurance status is exactly the kind of situation the Lilly Cares Foundation is designed for. In the meantime, LillyDirect self-pay pricing can serve as a bridge option while your application is processed.


How We Researched This Guide

This guide was prepared by the Refill Relay Editorial Team using publicly available manufacturer patient assistance program documentation, federal poverty level guidelines, Medicare Part D coverage policy for diabetes medications, and publicly available LillyDirect self-pay program materials.

Every article undergoes editorial review for accuracy, readability, and consistency before publication. Our goal is to explain patient assistance programs in clear language so patients and caregivers can access affordable medication with less friction.


References

  1. Eli Lilly and Company. Mounjaro Savings Card, Lilly Cares Foundation, and LillyDirect Program Materials.
  2. U.S. Food and Drug Administration. Mounjaro and Zepbound Prescribing Information.
  3. U.S. Department of Health and Human Services. Federal Poverty Level Guidelines.
  4. Centers for Medicare & Medicaid Services. Medicare Part D Formulary and Coverage Determination Guidance.
  5. Partnership for Prescription Assistance. Patient Assistance Program Standards.

About Refill Relay

Refill Relay publishes evidence-based educational resources that help patients understand prescription insurance, patient assistance programs, pharmacy benefits and medication access. Our editorial team combines manufacturer program research with practical guidance to make complex healthcare topics easier to navigate.

Editorial Standards

  • Evidence-based program research
  • Editorial review before publication
  • Regular updates when program eligibility rules change
  • Clear distinction between educational content and medical or financial advice

Related Resources

Editorial Policy: Refill Relay content is researched using publicly available manufacturer patient assistance program materials, federal poverty guidelines, and standard industry application practices. Every article is reviewed for clarity, accuracy and usefulness before publication.

Evan Brown
About the Author
Evan Brown — Medical Content Researcher

Evan Brown is a medical content researcher who specializes in translating complex healthcare policy — including manufacturer patient assistance programs and Medicare formulary rules — into clear, actionable guidance for patients.

View Full Profile →
Dr. Megan Harris, MD
Medical Review
Dr. Megan Harris, MD

Dr. Megan Harris, MD reviews health content for accuracy, checking eligibility criteria and program documentation practices against current manufacturer and CMS guidance.

View Full Profile →

Contact Refill Relay